Loading
Latest filing published 02 Dec 2022 for PDS Biotechnology Corp, €1.4M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Frank Bedu-Addo is a declared insider of PDS Biotechnology Corp, with filings sourced from SEC (Form 4). Between 15 June 2021 and 2 December 2022, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 December 2022, the filings show a share grant worth €1.6M in PDS Biotechnology Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations